Mortality is 17% higher than the national average.
According to the data published on July 8 by the DREES, the CEPIDC-INSERM and Public Health France, France has nearly 640,000 deaths per year. Cancers are the first officials, in front of cardio-neurovascular diseases, both in men and in women. They are the source of 27% of deaths (around 172,000 people). Even if an overall downward trend is emerging, certain types of cancer are still progressing, especially those of the pancreas (constantly increasing), lungs, bronchi and trachea in women.
The study of French analysts highlights important geographic disparities. According to their observations, the risk of dying from cancer varies depending on the region. In Guyana and Mayotte, it is especially true for stomach, prostate and uterus cancer. In Corsica, lung cancer is distinguished with mortality 24% higher than the national average. In Normandy, mortality in the event of cancer is 10% higher than at the national level, especially for liver, colon, prostate and breast tumors. In Brittany, melanoma mortality (skin cancer) is the highest.
In the Center-Val de Loire, Grand-Est and Nouvelle-Aquitaine regions, mortality from blood, brain or kidney cancer is higher than elsewhere. But the region which pays the heaviest tribute is undoubtedly the Hauts-de-France. Cancer mortality is 17% higher than the national average. And mortality rates exceed more than 20% the national level for frequent cancers like that of colon, liver, breast, prostate, and rarer cancers: lip and oral cavity, esophagus, bladder.
In question: more present risk factors than in other regions such as tobacco, alcohol, precariousness, and access to prevention and sometimes unequal care. However, according to Public Health France, almost 40% of cancers are attributable to modifiable risk factors. Residents of this region can therefore reduce their risk of cancer by improving their lifestyle.
Strengthening prevention, improving access to organized screening and guaranteeing rapid care paths remain absolute priorities to hope to reduce these regional inequalities and improve the health of these populations.
